secwatch.observer — SEC 8-K summary
======================================

Issuer:     Entrada Therapeutics, Inc. (TRDA)
CIK:        0001689375
Form:       8-K
Filed at:   2023-12-06T23:59:59+00:00
Accession:  0001104659-23-123805
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director John F. Crowley resigns from Entrada board; Chapman and Parmar fill committee vacancies
--------------------------------------------------------------------------------

- John F. Crowley resigned from Board, Audit Committee, and as Chair of Compensation Committee, effective December 5, 2023.
- Resignation not due to any disagreement with the Company's operations, policies, or practices.
- Board appointed Gina Chapman to Audit Committee and Kush M. Parmar, M.D., Ph.D. as member and Chair of Compensation Committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1689375/000110465923123805/0001104659-23-123805-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1689375/000110465923123805/tm2332272d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-123805

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer